SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in the Sudan

European Journal of Human Genetics

Volumn 12, Issue 1, 2004, Pages 66-74

  Mohamed, Hiba Salah ^a,b   Ibrahim, Muntaser Eltayeb ^a   Miller, Elinor Nancy ^b   White, Jacqueline Katie ^b   Cordell, Heather Jane ^b   Howson, Joanna McCammond McGill ^b   Peacock, Christopher Sean ^b   Khalil, Eltahir Awad Gasim ^a   El Hassan, Ahmed Mohamed ^a   Blackwell, Jenefer Mary ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Association; Leishmaniasis; Linkage; SLC11A1 ( = NRAMP1)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PROTEIN SLC11A1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALLELE; BINDING SITE; CONTROLLED STUDY; ETHNIC DIFFERENCE; EXON; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INCIDENCE; INTRON; LEISHMANIA DONOVANI; LINKAGE ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NONPARAMETRIC TEST; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SCORING SYSTEM; SEQUENCE ANALYSIS; SUDAN; VISCERAL LEISHMANIASIS;

ANALYSIS OF VARIANCE; CATION TRANSPORT PROTEINS; DISEASE SUSCEPTIBILITY; GENE FREQUENCY; GENETIC MARKERS; HAPLOTYPES; HUMANS; LEISHMANIASIS, VISCERAL; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; SUDAN;

LEISHMANIA DONOVANI; PROTOZOA;

EID: 10744230828     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201089     Document Type: Review

References (60)

1. De Beer P, Harith AE, van Grootheest M, Winkler A: Outbreak of kala-azar in The Sudan. Lancet 1990; 335: 224.
2. Perea WA, Moren A, Ancelle T, Sondorp E: Epidemic of visceral leishmaniasis in southern Sudan. Lancet 1989; ii: 1222-1223.
3. Zijlstra EE, El Hassan AM, Ismael A, Ghalib HW: Endemic kalaazar in Eastern Sudan, a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 1994; 51: 826-836.
4. El Hassan AM, Zilijstra EE, Ismael A, Ghalib HW: Recent observations on the epidemiology of kala-azar in the eastern and central states of The Sudan. Trop Geograph Med 1995; 47: 151-156.
5. Ibrahim ME, Lambson B, Yousif AO et al: Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg 1999; 61: 941-944.
6. Bradley DJ, Kirkley J: Variation in susceptibility of mouse strains to Leishmania donovani infection. Trans R Soc Trop Med Hyg 1972; 66: 527-528.
7. Bradley DJ: Genetic control of natural resistance to Leishmania donovani. Nature 1974; 250: 353-354.
8. Bradley DJ, Kirkley J: Regulation of Leishmania populations within the host. I. The variable course of Leishmania donovani infections in mice. Clin Exp Immunol 1977; 30: 119-129.
9. Bradley DJ: Regulation of Leishmania populations within the host. II. Genetic control of acute susceptibility of mice to Leishmania donovani infection. Clin Exp Immunol 1977; 30: 130-140.
10. Bradley DJ, Taylor BA, Blackwell J, Evans EP, Freeman J: Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin Exp Immunol 1979; 37: 7-14.
11. Plant J, Glynn AA: Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice. Nature 1974; 248: 345-347.
12. Plant J, Glynn AA: Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis 1976; 133: 72-78.
13. Plant J, Glynn AA: Locating salmonella resistance gene on mouse Chromosome 1. Clin Exp Immunol 1979; 37: 1-6.
14. Gros F, Skamene E, Forget A: Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 1981; 127: 2417-2421.
15. Brown IN, Glynn AA, Plant J: Inbred mouse strain resistance to Mycobacterium lepraemurium follows the Ity/Lsh pattern. Immunology 1982; 47: 149-156.
16. Skamene E, Gros P, Forget A, Patel PJ, Nesbitt MN: Regulation of resistance to leprosy by chromosome 1 locus in the mouse. Immunogenetics 1984; 19: 117-124.
17. Goto Y, Buschman E, Skamene E: Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene. Immunogenetics 1989; 30: 218-221.
18. Vidal SM, Malo D, Vogan K, Skamene E, Gros P: Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993; 73: 469-485.
19. Goswami T, Bhattacharjee A, Babal P et al: Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J 2001; 354: 511-519.
20. Vidal S, Tremblay ML, Govoni G et al: The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995; 182: 655-666.
21. Gruenheid S, Pinner E, Desjardins M, Gros P: Natural resistance to infections with intracellular pathogens: The Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med 1997; 185: 717-730.
22. Searle S, Bright NA, Roach TIA et al: Localisation of Nramp1 in macrophages: modulation with activation and infection. J Cell Sci 1998; 111: 2855-2866.
23. Abel L, Sanchez FO, Oberti J et al: Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 1998; 177: 133-145.
24. Shaw M-A, Collins A, Peacock CS et al: Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tuberc Lung Dis 1997; 78: 35-45.
25. Greenwood CM, Fujiwara TM, Boothroyd LJ et al: Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000; 67: 405-416.
26. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Whittle HC, Hill AVS: Variation in the NRAMP1 gene is associated with susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
27. Ryu S, Park YK, Bai GH, Kim SJ, Park SN, Kang S: 3′UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. Int J Tuberc Lung Dis 2000; 4: 577-580.
28. Gao PS, Fujishima S, Mao XQ et al: Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin Genet 2000; 58: 74-76.
29. Cervino AC, Lakiss S, Sow O, Hill AV: Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry. Ann Hum Genet 2000; 64: 507-512.
30. Marquet S, Sanchez FO, Arias M et al: Variants of the human NRAMP1 gene and altered human immunodeficiency virus infection susceptibility. J Infect Dis 1999; 180: 1521-1525.
31. Shaw M-A, Clayton D, Atkinson SE et al: Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J Med Genet 1996; 33: 672-677.
32. Hofmeister A, Neibergs HL, Pokorny RM, Galanduik S: The natural resistance-associated macrophage protein gene is associated with Crohn's disease. Surgery 1997; 122: 173-179.
33. Esposito L, Hill NJ, Pritchard LE et al: Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. IMDIAB Group. Diabetes 1998; 47: 1797-1799.
34. Singal DP, Li J, Zhu Y, Zhang G: NRAMP1 gene polymorphisms in patients with rheumatoid arthritis. Tissue Antigens 2000; 55: 44-47.
35. Yang YS, Kim SJ, Kim JW, Koh EM: NRAMP1 gene polymorphisms in patients with rheumatoid arthritis in Koreans. J Korean Med Sci 2000; 15: 83-87.
36. Maliarik MJ, Chen KM, Sheffer RG et al: The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol 2000; 22: 672-675.
37. Sanjeevi CB, Miller EN, Dabadghao P et al: Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum 2000; 43: 1397-1404.
38. Zijlstra EE, el-Hassan AM: Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95 (Suppl 1): S27-S58.
39. Zijlstra EE, el-Hassan AM: Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95 (Suppl 1): S59-S76.
40. Liu J, Fujiwara TM, Buu NT et al: Identification of polymorphisms and sequence variants in human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995; 56: 845-853.
41. Copeman JB, Cucca C, Hearne CM et al: Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995; 9: 80-85.
42. Blackwell JM, Barton CH, White JK et al: Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med 1995; 1: 194-205.
43. Buu NT, Cellier M, Gros P, Schurr E: Identification of a highly polymorphic length variant in the 3′UTR of NRAMP1. Immunogenetics 1995; 42: 428-429.
44. Gudbjartsson DF, Jonasson K, Frigge ML, Kong A: Allegro, a new computer program for multipoint linkage analysis. Nat Genet 2000; 25: 12-13.
45. Peacock CS, Collins A, Shaw MA et al: Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol 2001; 20: 383-396.
46. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
47. Sham PC, Curtis D: An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59: 323-336.
48. Dudbridge F, Koeleman BF, Todd JA, Clayton DG: Unbiased application of the transmission disequilibrium test to multilocus haplotypes. Am J Hum Genet 2000; 66: 2009-2012.
49. Cordell HJ, Clayton DG: A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002; 70: 124-141.
50. Hedrick PW: Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117: 331-341.
51. Cellier M, Govoni G, Vidal S et al: Human natural resistance-associated macrophage protein: cDNA cloning chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med 1994; 180: 1741-1752.
52. Searle S, Blackwell JM: Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune vs infectious disease susceptibility. J Med Genet 1999; 36: 295-299.
53. Lenardo MJ, Baltimore D: NF-kB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989; 58: 227-229.
54. Bucheton B, Abel L, Kheir MM et al: Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun 2003; 4: 104-109.
55. Kotze MJ, de Villiers JN, Rooney RN et al: Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. Blood Cells Mol Dis 2001; 27: 44-53.
56. Swingler S, Morris A, Easton A: Tumour necrosis factor alpha and interleukin-1 beta induce specific subunits of NFKB to bind the HIV-1 enhancer: characterisation of transcription factors controlling human immunodeficiency virus type 1 gene expression in neural cells. Biochem Biophys Res Commun 1994; 203: 623-630.
57. Barral-Netto M, Badaro, R, Barral A et al: Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Inrect Dis 1991; 163: 853-857.
58. Awomoyi AA, Marchant A, Howson JM, McAdam KP, Blackwell JM, Newport MJ: Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Inrect Dis 2002; 186: 1804-1814.
59. Blackwell JM, Goswami T, Evans CAW et al: SLC11A1 (formerly NRAMP1) and disease. Cell Microbiol 2001; 3: 773-784.
60. Blackwell JM, Searle S, Goswami T, Miller EN: Understanding the multiple functions of Nramp1. Microbes Infect 2000; 2: 317-321.